These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 3071331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
    Antin JH, Smith BR, Holmes W, Rosenthal DS.
    Blood; 1988 Aug; 72(2):705-13. PubMed ID: 3042046
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes.
    Hoelzer D, Ganser A, Völkers B, Greher J, Walther F.
    Blood Cells; 1988 Aug; 14(2-3):551-9. PubMed ID: 3067785
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancy.
    Vadhan-Raj S, Kellagher MJ, Keating M, Walters R, Gutterman JU.
    Behring Inst Mitt; 1988 Aug; (83):119-24. PubMed ID: 2467646
    [Abstract] [Full Text] [Related]

  • 7. Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: a phase ib clinical study.
    Herrmann F, Schulz G, Lindemann A, Meyenburg W, Oster W, Krumwieh D, Mertelsmann R.
    Behring Inst Mitt; 1988 Aug; (83):107-18. PubMed ID: 2467645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation.
    Blazar BR, Widmer MB, Kersey JH, Ramsay NK, McGlave PB, Urdal DL, Gillis S, Henney C, Vallera DA.
    Behring Inst Mitt; 1988 Aug; (83):170-80. PubMed ID: 3071335
    [Abstract] [Full Text] [Related]

  • 15. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
    Nissen-Druey C.
    Nouv Rev Fr Hematol (1978); 1989 Aug; 31(2):99-101. PubMed ID: 2475852
    [No Abstract] [Full Text] [Related]

  • 16. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R.
    Cancer; 2003 Dec 01; 98(11):2410-9. PubMed ID: 14635076
    [Abstract] [Full Text] [Related]

  • 17. Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia.
    Antin JH, Weinberg DS, Rosenthal DS.
    Exp Hematol; 1990 May 01; 18(4):266-70. PubMed ID: 2182331
    [Abstract] [Full Text] [Related]

  • 18. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man.
    Linch DC, Devereux S, Addison IE.
    Behring Inst Mitt; 1988 Aug 01; (83):320-3. PubMed ID: 3071347
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan 01; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.